Human Anti-CD99 / MIC2 Antibody Product Attributes
Tested Applications: Immunohistochemistry (IHC).
Clonality: Recombinant Monoclonal
Anti-CD99 / MIC2 Antibody Clone: MIC2/1495R
Clone MIC2/1495R Host and Isotype: Rabbit IgG kappa
Anti-Human CD99 / MIC2 Positive Control Sample: MOLT-4 cells. Pancreas or Ewing s sarcoma
Cellular Localization of Antibody
Buffer and Stabilizer: 10mM PBS with or without 0.05% BSA & 0.05% azide.
Antibody Concentration: 200ug/ml
Antibody Purification Method:Protein A/G Purified
Immunogen: Recombinant human full-length MIC2 protein
Storage Conditions: Store at 2 to 8Â° C (refrigerate). Stable for 24 months when properly stored.
CD99 / MIC2 Previously Observed Antibody Staining Patterns
Observed Subcellular, Organelle Specific Staining Data:Anti-CD99 antibody staining is expected to be primarily localized to the golgi apparatus.
Observed Antibody Staining Data By Tissue Type:Variations in CD99 / MIC2 antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in cells in the endometrial stroma in endometrium, cells in the red pulp in spleen, cells in the seminiferous ducts in testis, glandular cells in the cervix, uterine and prostate, hematopoietic cells in the bone marrow, islets of Langerhans in pancreas, ovarian stroma cells in the ovary, respiratory epithelial cells in the nasopharynx and squamous epithelial cells in the esophagus. More moderate antibody staining intensity was present in cells in the endometrial stroma in endometrium, cells in the red pulp in spleen, cells in the seminiferous ducts in testis, glandular cells in the cervix, uterine and prostate, hematopoietic cells in the bone marrow, islets of Langerhans in pancreas, ovarian stroma cells in the ovary, respiratory epithelial cells in the nasopharynx and squamous epithelial cells in the esophagus. Low, but measureable presence of CD99 / MIC2 could be seen inadipocytes in mesenchymal tissue, cells in the white pulp in spleen, endothelial cells in the colon, follicle cells in the ovary, glandular cells in the breast, duodenum, endometrium, epididymis and gallbladder, macrophages in lung, non-germinal center cells in the tonsil and squamous epithelial cells in the tonsil. We were unable to detect CD99 / MIC2 in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.
Observed Antibody Staining Data By Tissue Disease Status:Tissues from cancer patients, for instance, have their own distinct pattern of CD99 / MIC2 expression as measured by anti-CD99 / MIC2 antibody immunohistochemical staining. The average level of expression by tumor is summarized in the table below. The variability row represents patient to patient variability in IHC staining.
|Sample Type||breast cancer||carcinoid||cervical cancer||colorectal cancer||endometrial cancer||glioma||head and neck cancer||liver cancer||lung cancer||lymphoma||melanoma||ovarian cancer||pancreatic cancer||prostate cancer||renal cancer||skin cancer||stomach cancer||testicular cancer||thyroid cancer||urothelial cancer|
Limitations and Warranty
enQuire Bio's CD99 / MIC2 Recombinant Monoclonal is available for Research Use Only. This antibody is guaranteed to work for a period of two years when properly stored.
There are no reviews yet.